NMRA vs PFG · $283.5M cap vs P/E 16, rev $16.13B
Neumora Therapeutics, Inc. (NMRA) versus Principal Financial Group Inc (PFG) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Principal Financial Group Inc (PFG) is a asset management company listed on NASDAQ.
NMRA does not have a complete income-statement cache yet.
Latest reported PFG revenue for 2024-12-31 was $16.13B. Net income was $1.60B. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
NMRA currently screens at market cap $283.5M. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
Not investment advice. Open the NMRA and PFG stock pages for the full models.
Not investment advice.